Synthesis of p-trifluoroacetamidophenyl beta-D-glucopyranoside 4-(D-ribit-5-yl phosphate) corresponding to the Haemophilus influenzae type A capsular antigen.
The synthesis is described of the title glycoside which corresponds to the Haemophilus influenzae type a capsular antigen. The hydrogenphosphonate method was used with 3,3'-(chlorophosphonylidene)bis(2-oxo-1,3-oxazolidene) as the condensing agent.
Classon
B
B
Department of Organic Chemistry, Arrhenius Laboratory, University of Stockholm, Sweden.
Garegg
P J
PJ
Lindh
I
I
D000942:Antigens, Bacterial / Q000138:chemical synthesis*; D016667:Bacterial Capsules; D001428:Bacterial Vaccines / Q000138:chemical synthesis; D002236:Carbohydrate Conformation; D055598:Chemical Phenomena; D002621:Chemistry; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae; D007202:Indicators and Reagents; D009682:Magnetic Resonance Spectroscopy; D015394:Molecular Structure; D011135:Polysaccharides, Bacterial / Q000138:chemical synthesis*; D013403:Sugar Phosphates / Q000138:chemical synthesis*
D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; D007202:Indicators and Reagents; D011135:Polysaccharides, Bacterial; D013403:Sugar Phosphates; C058135:4-trifluoroacetamidophenyl-1-O-glucopyranosylribitol-1'-phosphate